What is your profession?
MDNP DOOncology Nurse PhDNurse PA/PA-COther (please specify)

What Board Certifications do you have?
Med OncOncology Surgeon HematologistInternal Medicine Hem/OncFamily Practice Surgical OncOther (please specify) Radiation Onc

What is your primary specialty?
General OncologyHead, Neck, or Lung Cancers Gastrointestinal CancersGynecologic Cancer Genitourinary CancersHematological Malignancies Breast CancerOther

May we e-mail you for further clarification of your comments?
Yes No

How would you describe this course to your colleagues?

What in the program description did you find most compelling? Did your experience match your expectations?

Have you attended a prior Dana-Farber Master Class for Oncologists?
Yes No

If yes, how does this year’s program compare?

How does Dana-Farber Master Class compare to other CME programs you’ve attended?

Of the sessions currently in the course, which did you find MOST engaging? Please explain.

Which sessions did you find LEAST valuable? Please explain.

What activity or topic would you like to see in future Master Class courses? Please explain.

Please identify and provide feedback (knowledge, quality of presentation style, level of content) for each track you attended.

Please identify you how you will use information from each track in your clinical practice.

Select the tracks you attended


	Success You have claimed credit successfully. Print your certificate

April 27-28 Chicago, IL

Course complete: Registration is closed.

Agenda

Accreditation

Agenda

Friday

06:30 AM - 07:15 AM	Registration and Breakfast
07:15 AM - 07:30 AM	Opening Remarks

Hematologic Malignancies Track

07:30 AM - 08:20 AM	Lymphomas: Optimizing Use of the Current Therapeutic Armamentarium Arnold S. Freedman, MD; Track Director
08:00 AM - 09:00 AM	Chronic Lymphocytic Leukemia: Therapeutic Choices and Ongoing Management John C. Byrd, MD
08:20 AM - 09:15 AM	Myeloid Malignancies: Initial Therapeutic Decisions and Long Term Management
09:15 AM - 09:50 AM	Myeloproliferative Disorders: Recent Advances and Remaining Clinical Dilemmas Ayalew Tefferi, MD

09:50 AM - 10:05 AM	Break

Hematologic Malignancies Track

10:05 AM - 10:40 AM	Multiple Myeloma: Evidence-Driven Best Practices in 2012 Kenneth C. Anderson, MD

11:15 AM - 11:45 AM	Panel Discussion
11:45 AM - 02:00 PM	Lunch

Genitourinary Cancers Track

01:00 PM - 01:50 PM	Advanced and Metastatic Prostate Cancer: The Evolving Therapeutic Landscape Philip W. Kantoff, MD
01:50 PM - 02:25 PM	Bladder and Renal Cancer: Individualized Approaches and Evidence-Based Best Practices Robert Dreicer, MD

Lung, Head and Neck Cancers Track

02:25 PM - 03:15 PM	Head and Neck Cancer: Integrating Multiple Modalities into an Individualized Approach Robert I. Haddad, MD

03:15 PM - 03:30 PM	Break

Lung, Head and Neck Cancers Track

03:30 PM - 04:05 PM	Small Cell Lung Cancer: Current Best Practices and Emerging Clinical Data Bruce E. Johnson, MD; Track Director
04:05 PM - 05:05 PM	Non-Small Cell Lung Cancer Everett E. Vokes, MD

05:05 PM - 05:35 PM	Panel Discussion

Optional MOC Session

06:00 PM - 08:00 PM	MOC Session

Saturday

06:30 AM - 07:15 AM	Registration and Breakfast
07:15 AM - 07:30 AM	Opening Remarks

Gastrointestinal Cancer Track

07:30 AM - 08:20 AM	Esophaegeal, Gastric and Pancreatic Cancers: How to Improve Survival for These Deadly Cancers Peter C. Enzinger, MD
08:20 AM - 09:05 AM	Familial Gastrointestinal Cancers: Screening, Evaluating, and Managing Patients with Hereditary Gastrointestinal Cancers Sapna Syngal, MD, MPH
09:05 AM - 09:55 AM	Colorectal Cancers: The Influence of Diet and Lifestyle in Colorectal Cancer Charles S. Fuchs, MD, MPH

09:55 AM - 10:10 AM	Break
11:00 AM - 11:30 AM	Panel Discussion

Gynecologic Cancer Track

11:30 AM - 12:00 PM	Ovarian Cancer: Evidence-Based Best Practices and Emerging and Clinical Trial Results Ursula A. Matulonis, MD

12:00 PM - 01:00 PM	Lunch

Supportive Care Track

01:00 PM - 01:50 PM	Pallative and Supportive Care: A Comprehensive Guide to Caring for Your Patients Janet L. Abrahm, MD, FACP, FAAHPM

Breast Cancer Track

01:50 PM - 02:40 PM	High Risk Breast Cancer: The Evolving Management of High Risk Breast Cancer Patients Kenneth Offit, MD, MPH
02:40 PM - 03:30 PM	Individualized Treatment Strategies in Breast Cancer: Therapeutic Choices for HER2+, Triple Negative, and Other Subtypes Eric P. Winer, MD

03:30 PM - 03:45 PM	Break

Breast Cancer Track

03:45 PM - 04:25 PM	Hormone Receptor Positive Breast Cancer: Integrating Recent Clinical Data into Evidence-Based Best Practices Harold J. Burstein, MD, PhD; Track Director
04:25 PM - 05:00 PM	Breast Cancer Survivorship: Treating the Whole Patient - A Comprehensive Approach to Breast Cancer Survivorship Ann H. Partridge, MD, MPH

05:00 PM - 05:30 PM	Panel Discussion
05:30 PM - 05:35 PM	Adjournment

© Copyright Dana-Farber Cancer Institute. All rights reserved.
This course is jointly sponsored by Dana-Farber Cancer Institute, Knowledge to Practice and Annenberg Center for Health Sciences.

For questions or more information on our live courses or online activities, please contact:
Laurie Bertoncini, Program Manager
Phone: 610-361-9720 | Email: LBertoncini@KnowledgeToPractice.org